Farmers & Merchants Investments Inc’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$505 Hold
25
﹤0.01% 1688
2026
Q1
$490 Hold
25
﹤0.01% 1650
2025
Q4
$670 Hold
25
﹤0.01% 1559
2025
Q3
$666 Sell
25
-3
-11% -$77 ﹤0.01% 1573
2025
Q2
$643 Hold
28
﹤0.01% 1561
2025
Q1
$812 Hold
28
﹤0.01% 1505
2024
Q4
$1.04K Hold
28
﹤0.01% 1454
2024
Q3
$1.36K Hold
28
﹤0.01% 1375
2024
Q2
$1.12K Hold
28
﹤0.01% 1416
2024
Q1
$1.23K Hold
28
﹤0.01% 1360
2023
Q4
$1.73K Hold
28
﹤0.01% 1190
2023
Q3
$1.29K Hold
28
﹤0.01% 1268
2023
Q2
$1.61K Hold
28
﹤0.01% 1181
2023
Q1
$1.05K Hold
28
﹤0.01% 1365
2022
Q4
$785 Buy
28
+4
+17% +$116 ﹤0.01% 1479
2022
Q3
$1K Buy
+24
New +$784 ﹤0.01% 1148

Other funds holding AMPH

Farmers & Merchants Investments Inc's AMPH Position: Q2 2026 in Review

Farmers & Merchants Investments Inc held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 25 shares worth $505. The position accounts for ﹤0.01% of the portfolio, ranked #1688.

Farmers & Merchants Investments Inc first reported a position in AMPH in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.73K in Q4 2023. 82 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Farmers & Merchants Investments Inc held 25 shares of Amphastar Pharmaceuticals worth $505 as of Q2 2026.
  • Farmers & Merchants Investments Inc left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Farmers & Merchants Investments Inc's portfolio in Q2 2026, its #1688 holding.
  • Farmers & Merchants Investments Inc first reported a position in Amphastar Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • Farmers & Merchants Investments Inc's Amphastar Pharmaceuticals position peaked at $1.73K in Q4 2023.
  • 82 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2026, filed 20 Jul 2026.